Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway

Clinical trial NCT07024550 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07024550
Sponsor: BTL Industries Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Binge Eating Behaviour Binge Eating/Loss of Control Eating Food Craving

Start date: 2025-07-22
Primary completion: 2025-11-04
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.